These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
332 related items for PubMed ID: 31341787
1. The characterisation of pulmonary function in patients with mucopolysaccharidoses IVA: A longitudinal analysis. Kenth JJ, Thompson G, Fullwood C, Wilkinson S, Jones S, Bruce IA. Mol Genet Metab Rep; 2019 Sep; 20():100487. PubMed ID: 31341787 [Abstract] [Full Text] [Related]
2. Data in support of the longitudinal characterization of pulmonary function in children with Mucopolysaccharidoses IVA. Kenth JJ, Thompson G, Wilkinson S, Jones S, Bruce IA. Data Brief; 2019 Dec; 27():104756. PubMed ID: 31886335 [Abstract] [Full Text] [Related]
3. Characterization of pulmonary function impairments in patients with mucopolysaccharidoses--changes with age and treatment. Lin SP, Shih SC, Chuang CK, Lee KS, Chen MR, Niu DM, Chiu PC, Lin SJ, Lin HY. Pediatr Pulmonol; 2014 Mar; 49(3):277-84. PubMed ID: 23401495 [Abstract] [Full Text] [Related]
4. Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome. Tomatsu S, Sawamoto K, Alméciga-Díaz CJ, Shimada T, Bober MB, Chinen Y, Yabe H, Montaño AM, Giugliani R, Kubaski F, Yasuda E, Rodríguez-López A, Espejo-Mojica AJ, Sánchez OF, Mason RW, Barrera LA, Mackenzie WG, Orii T. Drug Des Devel Ther; 2015 Mar; 9():1937-53. PubMed ID: 25897204 [Abstract] [Full Text] [Related]
7. Clinical characteristics and effects of enzyme replacement therapy with elosulfase alfa in Korean patients with mucopolysaccharidosis type IVA. Lee SH, Kim HY, Cho TJ, Kim H, Ko JM. Mol Genet Metab Rep; 2022 Jun; 31():100869. PubMed ID: 35782601 [Abstract] [Full Text] [Related]
9. Molecular genetics and metabolism, special edition: Diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA. Peracha H, Sawamoto K, Averill L, Kecskemethy H, Theroux M, Thacker M, Nagao K, Pizarro C, Mackenzie W, Kobayashi H, Yamaguchi S, Suzuki Y, Orii K, Orii T, Fukao T, Tomatsu S. Mol Genet Metab; 2018 Sep; 125(1-2):18-37. PubMed ID: 29779902 [Abstract] [Full Text] [Related]
10. Natural history and galsulfase treatment in mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy syndrome)--10-year follow-up of patients who previously participated in an MPS VI Survey Study. Giugliani R, Lampe C, Guffon N, Ketteridge D, Leão-Teles E, Wraith JE, Jones SA, Piscia-Nichols C, Lin P, Quartel A, Harmatz P. Am J Med Genet A; 2014 Aug; 164A(8):1953-64. PubMed ID: 24764221 [Abstract] [Full Text] [Related]
13. Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA. Hendriksz CJ, Harmatz P, Beck M, Jones S, Wood T, Lachman R, Gravance CG, Orii T, Tomatsu S. Mol Genet Metab; 2013 Aug; 110(1-2):54-64. PubMed ID: 23665161 [Abstract] [Full Text] [Related]
14. Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment. Tomatsu S, Montaño AM, Oikawa H, Smith M, Barrera L, Chinen Y, Thacker MM, Mackenzie WG, Suzuki Y, Orii T. Curr Pharm Biotechnol; 2011 Jun; 12(6):931-45. PubMed ID: 21506915 [Abstract] [Full Text] [Related]
19. Development of a fluorometric microtiter plate based enzyme assay for MPS IVA (Morquio type A) using dried blood spots. Ullal AJ, Millington DS, Bali DS. Mol Genet Metab Rep; 2014 Jun; 1():461-464. PubMed ID: 27896123 [Abstract] [Full Text] [Related]